{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:36:10Z","timestamp":1753893370851,"version":"3.41.2"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To describe high\u2013velocity nasal insufflation (HVNI) for managing dogs with left\u2013sided congestive heart failure (L\u2013CHF) failing traditional oxygen therapy (TOT). To secondarily evaluate complications based on retrospective evaluation of the record of HVNI and survival to discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Retrospective case series from a university teaching hospital between August 2019 and October 2021.<\/jats:p><\/jats:sec><jats:sec><jats:title>Animals<\/jats:title><jats:p>Twelve dogs diagnosed with L-CHF and managed with HVNI.<\/jats:p><\/jats:sec><jats:sec><jats:title>Measurements and main results<\/jats:title><jats:p>Medical records were retrospectively reviewed for signalment, point-of-care diagnostics, and HVNI information. Nine dogs were diagnosed with myxomatous mitral valve disease, and three dogs were diagnosed with dilated cardiomyopathy. All dogs in this study required HVNI after failing TOT. Dogs were treated with HVNI for a median of 14\u202fh (range 2\u201322\u202fh). HVNI was successfully discontinued in 10 dogs (83%), all of which survived to discharge. Two dogs on HVNI were humanely euthanized, both of which were diagnosed with Stage D refractory CHF. No major complications of HVNI were noted in any dogs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>HVNI is a potential method of escalating oxygen support for dogs in L-CHF who fail TOT. In this case series, all dogs in which HVNI was successfully discontinued survived to discharge.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fvets.2025.1562633","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:38:15Z","timestamp":1746769095000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["High-velocity nasal insufflation in dogs with left-sided congestive heart failure unresponsive to traditional oxygen therapy: a retrospective case series"],"prefix":"10.3389","volume":"12","author":[{"given":"Bailey","family":"Lane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca A.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April E.","family":"Blong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"\u2018t Hoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa A.","family":"Tropf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allison K.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cvsm.2020.07.002","article-title":"Respiratory emergencies","volume":"50","author":"Tong","year":"2020","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1070881","DOI":"10.3389\/fvets.2023.1070881","article-title":"Clinical review of high-flow nasal oxygen therapy in human and veterinary patients","volume":"10","author":"Whitney","year":"2023","journal-title":"Front Vet Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/vec.12230","article-title":"Outcome of positive-pressure ventilation in dogs and cats with congestive heart failure: 16 cases (1992-2012)","volume":"24","author":"Edwards","year":"2014","journal-title":"J Vet Emerg Crit Care"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"100596","DOI":"10.1016\/j.tcam.2021.100596","article-title":"A review of high flow nasal cannula oxygen therapy in human and veterinary medicine","volume":"46","author":"Krawec","year":"2022","journal-title":"Top Companion Anim Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM consensus guidelines for the diagnosis and treatment of Myxomatous mitral valve disease in dogs","volume":"33","author":"Keene","year":"2019","journal-title":"J Vet Int Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"380686","DOI":"10.1155\/2012\/380686","article-title":"The effects of gas humidification with high-flow nasal cannula on cultured human airway epithelial cells","volume":"2012","author":"Chidekel","year":"2012","journal-title":"Pulm Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1476-4431.2010.00524.x","article-title":"Evaluation of acute congestive heart failure in dogs and cats: 145 cases (2007-2008)","volume":"20","author":"Goutal","year":"2010","journal-title":"J Vet Emerg Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/vec.13224","article-title":"Retrospective evaluation of the outcome and prognosis of undergoing positive pressure ventilation due to cardiac and noncardiac causes in dogs and cats (2019-2020): 101 cases","volume":"32","author":"Oppenheimer","year":"2022","journal-title":"J Vet Emerg Crit Care"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.47144\/phj.v55i1.2113","article-title":"Benefits of high-flow nasal oxygen therapy in acute heart failure","volume":"55","author":"Nugroho","year":"2022","journal-title":"Pak Heart J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e13372","DOI":"10.7759\/cureus.13372","article-title":"Physiological effects of high-flow nasal cannula therapy and its use in acute cardiogenic pulmonary edema","volume":"13","author":"Adhikari","year":"2021","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40560-017-0227-y","article-title":"Complex effects of high-flow nasal cannula therapy on hemodynamics in the pediatric patient after cardiac surgery","volume":"5","author":"Inata","year":"2017","journal-title":"J Intensive Care"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2460\/javma.22.09.0400","article-title":"High-flow nasal cannula improves hypoxemia in dogs failing conventional oxygen therapy","volume":"261","author":"Frischer","year":"2022","journal-title":"J Am Vet Med Assoc"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2161-105X.1000376","article-title":"Computational fluid dynamics modeling of extrathoracic airway flush: evaluation of high flow nasal cannula design elements","volume":"6","author":"Miller","year":"2016","journal-title":"J Pulm Respir Med"},{"key":"ref14","first-page":"7","article-title":"Impact of high flow nasal cannula in dogs with hypoxemia","author":"Daly","year":"2016"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/ppul.25214","article-title":"Pediatric high-flow nasal cannula protocol standardizes initial flow and expedites weaning","volume":"56","author":"Wiser","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/vec.12495","article-title":"Retrospective evaluation of the effect of high flow oxygen therapy delivered by nasal cannula on PaO2 in dogs with moderate-to-severe hypoxemia","volume":"26","author":"Keir","year":"2016","journal-title":"J Vet Emerg Crit Care"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/jp.2017.24","article-title":"Consensus approach to nasal high-flow therapy in neonates","volume":"37","author":"Yoder","year":"2017","journal-title":"J Perinatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.rmed.2009.04.007","article-title":"Research in high flow therapy: mechanisms of action","volume":"103","author":"Dysart","year":"2009","journal-title":"Respir Med"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1562633\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:38:15Z","timestamp":1746769095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2025.1562633\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":18,"alternative-id":["10.3389\/fvets.2025.1562633"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2025.1562633","relation":{},"ISSN":["2297-1769"],"issn-type":[{"type":"electronic","value":"2297-1769"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"article-number":"1562633"}}